Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Critical Thinking II01:25

Critical Thinking II

Critical thinking is a cognitive process with several attributes. The attributes of critical thinking include the following:
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Nursing Interventions II: Selecting and Classifying the Nursing Interventions01:29

Nursing Interventions II: Selecting and Classifying the Nursing Interventions

Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness thresholds used in the United States vs most favored nations.

Health affairs scholar·2026
Same author

FDA approvals of specialty drugs, 2000-2024.

Health affairs scholar·2026
Same author

Communication of launch prices by drug companies, 2022-2024.

The American journal of managed care·2026
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

When Do Published Cost-Effectiveness Analyses Include Societal Costs? An Empirical Analysis, 2013-2023.

Medical decision making : an international journal of the Society for Medical Decision Making·2025
Same journal

National Health Expenditure Projections, 2025-34: Strong Utilization Growth Initially, Legislative Impacts Later.

Health affairs (Project Hope)·2026
Same journal

State Medicaid Programs Face Increased Spending On Medicare Premiums.

Health affairs (Project Hope)·2026
Same journal

Not enough time.

Health affairs (Project Hope)·2026
Same journal

Medicaid Tobacco And Nicotine Cessation Treatment Rates Remained Low, 2019-24.

Health affairs (Project Hope)·2026
Same journal

Third-Party Convener Firms And The Rise Of Geographically Dispersed, High-Earning Medicare ACOs.

Health affairs (Project Hope)·2026
Same journal

The Opacity Of Price Transparency.

Health affairs (Project Hope)·2026
See all related articles

Related Experiment Videos

Using decision analysis to better evaluate pediatric clinical guidelines.

Joshua T Cohen1, Peter J Neumann

  • 1Tufts Medical Center, Center for the Evaluation of Value and Risk (CEVR), Boston, Massachusetts, USA. jcohen@TuftsMedicalCenter.org

Health Affairs (Project Hope)
|September 11, 2008
PubMed
Summary
This summary is machine-generated.

Existing clinical guideline criteria often rely on study design over true evidence quality. Decision analysis offers a superior method for evaluating evidence and net benefits, especially in pediatric research.

Related Experiment Videos

Area of Science:

  • Health policy
  • Clinical decision-making
  • Evidence-based medicine

Background:

  • Current clinical guideline evidentiary criteria frequently use study design as a proxy for evidence quality.
  • These criteria often fail to independently assess evidence quality, net benefits, and research needs.
  • This approach is particularly problematic in pediatric research where randomized controlled trials are often impractical.

Purpose of the Study:

  • To propose decision analysis as a method to augment traditional frameworks for clinical guidelines.
  • To highlight the utility of decision analysis in quantifying potential net benefits using available evidence.
  • To advocate for the integration of decision analysis into comparative effectiveness research and clinical guideline development.

Main Methods:

  • Decision analysis is presented as a quantitative framework.
  • The method quantifies the range of potential net benefits based on available evidence.
  • The approach is discussed in the context of pediatric research challenges.

Main Results:

  • Decision analysis can systematically characterize evidence quality and net benefits.
  • It provides a robust method for evaluating evidence when high-level study designs are unavailable.
  • The framework is particularly advantageous for pediatric populations.

Conclusions:

  • Decision analysis offers a valuable supplement to existing evidentiary criteria for clinical guidelines.
  • Policymakers should consider incorporating decision analysis into comparative effectiveness research.
  • Integrating decision analysis can improve the quality and applicability of clinical guidelines, especially for pediatric care.